Board Change • Jun 29
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Doug Bachman was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Mar 02
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Doug Bachman was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Feb 18
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 58% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Shareholders have been substantially diluted in the past year (58% increase in shares outstanding). Market cap is less than US$10m (CA$10.2m market cap, or US$7.45m). 공고 • Dec 10
SureNano Science Ltd. announced that it has received CAD 1.25 million in funding On December 10, 2025, SureNano Science Ltd. closed the transaction. In connection with the private placement, the company paid cash commissions of CAD 75,000 and issued an aggregate of 600,000 finder's warrants to certain brokerage firms and agents for introducing subscribers to the company. Each finder's warrant entitles the holder to receive one common share in the capital of the company at a price of CAD 0.35 per common share for a period of 24 months from the date of issuance, subject to the acceleration provision. 공고 • Nov 06
SureNano Science Ltd. announced that it expects to receive CAD 1.25 million in funding SureNano Science Ltd. announced a private placement of up to 10,000,000 units at a price of CAD 0.125 per unit for proceeds of up to CAD 1,250,000 on November 5, 2025. Each unit will be comprised of one common share and one common share purchase warrant, with each warrant entitling the holder thereof to acquire one common share in the capital of the company at a price of CAD 0.35 per common share for a period of 24 months from the date of issuance. In consideration for their services in introducing subscribers to the company under the private placement, finders may receive commission of 6% cash and 6% common share purchase warrants, exercisable to purchase one common share at a price of CAD 0.35 for a period of 24 months. All securities issued in the private placement will be subject to a four month and a day hold period. 공고 • Aug 22
SureNano Science Ltd. announced that it expects to receive CAD 0.215 million in funding SureNano Science Ltd. announced a private placement to issue 2,100,000 common shares at an issue price of CAD 0.10 per share for gross proceeds of CAD 215,000 on August 22, 2025. All securities issued in the private placement will be subject to a four month and a day hold period. . Up to 3,000,000 Private Placement and Debt Settlement shares in total be issued at a price of $0.10 per share subject to CSE approval. 공고 • Jun 10
SureNano Science Ltd., Annual General Meeting, Aug 08, 2025 SureNano Science Ltd., Annual General Meeting, Aug 08, 2025. 공고 • Nov 21
SureNano Science Ltd., Annual General Meeting, Feb 09, 2024 SureNano Science Ltd., Annual General Meeting, Feb 09, 2024. 공고 • Nov 25
SureNano Science Ltd. Approves Board Changes SureNano Science Ltd. at its annual general and special meeting held on November 24, 2022, approved to elect Doug Bachman as a new member of the Company's board of Directors. Mr. Bachman is currently a director of Rebel Capital 2.0 Corp. Mr. Bachman also acts as a consultant advising private and public companies on M&A activity. Mr. Bachman brings more than 25 years' experience of Corporate Finance and Management from a major financial institution. This experience has provided him with extensive knowledge in credit, wealth management, team building and leadership. Mark Scott has stepped down from his role as Director. 공고 • Sep 13
SureNano Science Ltd., Annual General Meeting, Nov 24, 2022 SureNano Science Ltd., Annual General Meeting, Nov 24, 2022.